Tempest Therapeutics TPST
NASDAQ TPST
$0.80 -0.11 (-11.70%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026)

Tempest Therapeutics' (TPST) quarterly Prepaid Assets came in at $918000.0 in Q2 2026, up 11.54% year-over-year from $823000.0 in Q2 2025, and up 63.35% quarter-over-quarter from $562000.0 in Q4 2025.

Analysis

Tempest Therapeutics (TPST) Prepaid Assets (2011 - 2026) Analysis & Trends

Tempest Therapeutics has disclosed Prepaid Assets across 16 years of filings, most recently posting $918000.0 for Q2 2026.

  • In Q2 2026, Prepaid Assets rose 11.54% year-over-year to $918000.0; the TTM figure through Jun 2026 stood at $918000.0 (up 11.54% YoY), while the FY2025 annual figure was $562000.0, down 53.4% from the prior year.
  • Prepaid Assets came in at $918000.0 for Q2 2026 at Tempest Therapeutics, up from $562000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.3 million in Q3 2022 to a low of $424000.0 in Q2 2024.
  • Average Prepaid Assets over 5 years is $1.2 million, with a median of $1.2 million recorded in 2024.
  • The largest YoY upside for Prepaid Assets was 94.1% in 2025 against a maximum downside of 58.91% in 2025.
  • Over 5 years, Prepaid Assets stood at $1.3 million in 2022, then fell by 10.79% to $1.1 million in 2023, then rose by 6.44% to $1.2 million in 2024, then slumped by 53.4% to $562000.0 in 2025, then soared by 63.35% to $918000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $918000.0 in Q2 2026, $562000.0 in Q4 2025, and $590000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.21 Bn 9.37 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn -
3 Iovance Biotherapeutics 3.65 Bn 3.36 Bn 55.72 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
6 Beam Therapeutics 2.55 Bn 2.55 Bn -
7 Precigen 2.39 Bn 2.39 Bn 52.17 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Tempest Therapeutics 3.35 Mn 2.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 918,000.00
Dec 31, 2025 562,000.00
Sep 30, 2025 590,000.00
Jun 30, 2025 823,000.00
Mar 31, 2025 922,000.00
Dec 31, 2024 1.21 Mn
Sep 30, 2024 1.44 Mn
Jun 30, 2024 424,000.00
Mar 31, 2024 1.17 Mn
Dec 31, 2023 1.13 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 931,000.00
Mar 31, 2023 1.30 Mn
Dec 31, 2022 1.27 Mn
Sep 30, 2022 2.27 Mn
Jun 30, 2022 1.69 Mn
Mar 31, 2022 1.96 Mn
Dec 31, 2021 2.13 Mn
Sep 30, 2021 2.80 Mn
Jun 30, 2021 2.04 Mn